Morrisville · Biotech · North Carolina

11 Morrisville biotech startups

As of November 2026, Triangle Startups tracks 11 biotech startups headquartered in Morrisville, a Wake County town next to Research Triangle Park and Raleigh-Durham International Airport. In the twelve months to November 2026, Morrisville biotech startups disclosed $3.3 million across 1 funding round.

Latest recorded activity

Directory snapshot

Morrisville biotech startups by stage

Of 5 startups with a recorded funding stage, 1 are at grant, pre-seed, or seed. Reviewed jobs records currently show 6 open roles across 3 companies.

tracked startups
11
hiring now
3
grant through seed
1
By stageSeries A2Series B2Seed1

6 reviewed open roles

Which Morrisville biotech startups are hiring

See the jobs board

All 11 biotech startups headquartered in Morrisville

A

Arrivo BioVentures

Biotech · Series B

Clinical-stage drug developer with two candidates: forvisirvat (SP-624), a SIRT6 activator in Phase 2b/3 for major depressive disorder, and RABI-767 for predicted severe acute pancreatitis.

A

Artiam Bio

Biotech

Develops small-molecule CB1 cannabinoid receptor antagonists for liver disease, Prader-Willi syndrome and cannabis use disorder.

C

Clarus Biologics

Biotech

Develops vaccine and immunology technologies, including a virus-like-particle platform.

Codetta Bio

Codetta Bio

Biotech · Seed

Advanced multi-omic biomarker measurement tools for personalized health

DMC Biotechnologies

DMC Biotechnologies

Biotech

Morrisville precision-fermentation biomanufacturer producing bio-identical natural compounds at scale via the proprietary Dynamic Metabolic Control platform; lead product line is fermented KeyPura inositols.

D

Drive Therapeutics

Biotech

Preclinical biotech developing a bispecific aptamer drug that blocks VEGF and IL-8, starting with retinal diseases such as wet AMD and diabetic macular edema.

Inceptor Bio

Inceptor Bio

Biotech · Series A

Cell therapy company developing next-generation engineered cell therapies for solid tumors.

I

Inhalon Biopharma, Inc.

Biotech

Develops inhaled muco-trapping monoclonal antibodies for acute respiratory infections.

Lindy Biosciences

Lindy Biosciences

Biotech · Series A

Drug formulation technology with microglassification delivery systems

Locus Biosciences

Locus Biosciences

Biotech · Series B

Morrisville clinical-stage biotech engineering bacteriophage therapeutics with CRISPR-Cas3 payloads for antimicrobial-resistant bacterial infections and microbiome / inflammatory diseases.

N

NeuroGT, Inc.

Biotech

Develops AAV gene therapies for mucopolysaccharidoses, including Hurler, Hunter and Sanfilippo syndromes, and other rare neurogenetic diseases.

Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.